Marie Thibault
Stock Analyst at BTIG
(0.06)
# 4,768
Out of 5,060 analysts
763
Total ratings
38.4%
Success rate
-9%
Average return
Main Sectors:
Stocks Rated by Marie Thibault
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRC AtriCure | Reiterated: Buy | $55 → $63 | $56.07 | +12.36% | 55 | Oct 12, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $56 | $44.39 | +26.15% | 80 | Oct 12, 2026 | |
| DXCM DexCom | Reiterated: Buy | $90 → $96 | $86.04 | +11.58% | 57 | Oct 12, 2026 | |
| EMBC Embecta | Reiterated: Hold | n/a | $6.27 | - | 29 | Oct 9, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $110 | $86.60 | +27.02% | 46 | Oct 9, 2026 | |
| HYPR Hyperfine | Reiterated: Buy | $2 | $0.7548 | +164.97% | 9 | Oct 9, 2026 | |
| MMED MiniMed Group | Reiterated: Buy | $28 | $17.49 | +60.09% | 6 | Oct 9, 2026 | |
| PLSE Pulse Biosciences | Reiterated: Buy | $70 | $44.43 | +57.55% | 2 | Oct 9, 2026 | |
| SENS Senseonics Holdings | Reiterated: Hold | n/a | $7.77 | - | 41 | Oct 9, 2026 | |
| HAE Haemonetics | Reiterated: Buy | $84 → $130 | $118.28 | +9.91% | 14 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $25.04 | +19.81% | 14 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $27.24 | +17.47% | 12 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $10 | $5.45 | +83.49% | 9 | Sep 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $134 | $104.89 | +27.75% | 54 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $185 | $108.64 | +70.29% | 62 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $141.10 | - | 51 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $17 | $14.08 | +20.74% | 31 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.16 | - | 16 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.1557 | - | 39 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $3.94 | +280.71% | 18 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 | $59.19 | n/a | 55 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $343.46 | n/a | 1 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $320.86 | n/a | 1 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 37 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $89 | $94.75 | n/a | 1 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.89 | n/a | 23 | Dec 16, 2022 |
AtriCure
Oct 12, 2026
Reiterated: Buy
Price Target: $55 → $63
Current: $56.07
Upside: +12.36%
Boston Scientific
Oct 12, 2026
Reiterated: Buy
Price Target: $56
Current: $44.39
Upside: +26.15%
DexCom
Oct 12, 2026
Reiterated: Buy
Price Target: $90 → $96
Current: $86.04
Upside: +11.58%
Embecta
Oct 9, 2026
Reiterated: Hold
Price Target: n/a
Current: $6.27
Upside: -
Edwards Lifesciences
Oct 9, 2026
Reiterated: Buy
Price Target: $110
Current: $86.60
Upside: +27.02%
Hyperfine
Oct 9, 2026
Reiterated: Buy
Price Target: $2
Current: $0.7548
Upside: +164.97%
MiniMed Group
Oct 9, 2026
Reiterated: Buy
Price Target: $28
Current: $17.49
Upside: +60.09%
Pulse Biosciences
Oct 9, 2026
Reiterated: Buy
Price Target: $70
Current: $44.43
Upside: +57.55%
Senseonics Holdings
Oct 9, 2026
Reiterated: Hold
Price Target: n/a
Current: $7.77
Upside: -
Haemonetics
Oct 8, 2026
Reiterated: Buy
Price Target: $84 → $130
Current: $118.28
Upside: +9.91%
Sep 21, 2026
Reiterated: Buy
Price Target: $30
Current: $25.04
Upside: +19.81%
Sep 15, 2026
Reiterated: Buy
Price Target: $32
Current: $27.24
Upside: +17.47%
Sep 10, 2026
Upgraded: Buy
Price Target: $10
Current: $5.45
Upside: +83.49%
Aug 20, 2026
Reiterated: Buy
Price Target: $134
Current: $104.89
Upside: +27.75%
Aug 7, 2026
Reiterated: Buy
Price Target: $185
Current: $108.64
Upside: +70.29%
Aug 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $141.10
Upside: -
Jul 13, 2026
Reiterated: Buy
Price Target: $16 → $17
Current: $14.08
Upside: +20.74%
Jul 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.16
Upside: -
Jul 7, 2026
Rated: Hold
Price Target: n/a
Current: $0.1557
Upside: -
Feb 18, 2026
Reiterated: Buy
Price Target: $15
Current: $3.94
Upside: +280.71%
Apr 10, 2025
Reiterated: Buy
Price Target: $62
Current: $59.19
Upside: n/a
Oct 27, 2023
Reiterated: Buy
Price Target: $150
Current: $343.46
Upside: n/a
Jul 26, 2023
Rated: Buy
Price Target: n/a
Current: $320.86
Upside: n/a
Jul 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Feb 21, 2023
Rated: Hold
Price Target: $89
Current: $94.75
Upside: n/a
Dec 16, 2022
Rated: Hold
Price Target: n/a
Current: $1.89
Upside: n/a